Literature DB >> 16042419

Factor XIa dimer in the activation of factor IX.

Dipali Sinha1, Mariola Marcinkiewicz, James D Lear, Peter N Walsh.   

Abstract

Factor XI, unlike other coagulation proteins, is a homodimer of two identical subunits linked by a single disulfide bond formed by Cys321. The present study was undertaken to understand the physiological significance of the dimeric nature of factor XI. We have expressed a mutant FXI/G326C in which the Gly326 residue of factor XI has been mutated to Cys326, reasoning that Cys321 would form an intrachain disulfide bond with Cys326 as in prekallikrein, a plasma protein that exists as a monomer even with 58% amino acid sequence identity and a domain structure very similar to factor XI. No free thiol could be detected in the expressed protein, and it migrated as a monomer on nonreduced SDS-PAGE. In physiological buffer, however, the protein was found to exist in a state of monomer-dimer equilibrium as assessed by gel-filtration chromatography and ultracentrifugation studies (K(d) approximately 36 nM). Functional studies revealed that FXI/G326C was indistinguishable from plasma factor XI in a plasma-clotting assay and in a factor IX activation assay both in the presence and absence of activated platelets even at concentrations at which less than 5% of the mutant exists as dimers. We conclude that, for optimal function in the presence of activated platelets, a preformed dimer of factor XI is not required.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042419     DOI: 10.1021/bi050361x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.

Authors:  Mariola M Marcinkiewicz; Dipali Sinha; Peter N Walsh
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

2.  Dimer dissociation and unfolding mechanism of coagulation factor XI apple 4 domain: spectroscopic and mutational analysis.

Authors:  Paul W Riley; Hong Cheng; Dharmaraj Samuel; Heinrich Roder; Peter N Walsh
Journal:  J Mol Biol       Date:  2006-12-29       Impact factor: 5.469

3.  Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.

Authors:  Wenman Wu; Dipali Sinha; Sergei Shikov; Calvin K Yip; Thomas Walz; Paul C Billings; James D Lear; Peter N Walsh
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

Review 4.  Update on the physiology and pathology of factor IX activation by factor XIa.

Authors:  Stephen B Smith; David Gailani
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

5.  A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.

Authors:  Tara N Miller; Dipali Sinha; T Regan Baird; Peter N Walsh
Journal:  Biochemistry       Date:  2007-11-17       Impact factor: 3.162

6.  Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain.

Authors:  Kemin Tan; Mark Duquette; Jin-Huan Liu; Kumaran Shanmugasundaram; Andrzej Joachimiak; John T Gallagher; Alan C Rigby; Jia-huai Wang; Jack Lawler
Journal:  J Biol Chem       Date:  2007-12-07       Impact factor: 5.157

Review 7.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.